Nightingale Health Oyj (HEL:HEALTH)
0.8580
+0.0340 (4.13%)
At close: Jul 27, 2026
Nightingale Health Oyj Revenue
Nightingale Health Oyj had revenue of 2.41M EUR in the half year ending December 31, 2025, with 40.52% growth. This brings the company's revenue in the last twelve months to 4.80M, down -3.13% year-over-year. In the fiscal year ending June 30, 2025, Nightingale Health Oyj had annual revenue of 4.69M with 7.69% growth.
Revenue (ttm)
4.80M
Revenue Growth
-3.13%
P/S Ratio
10.80
Revenue / Employee
46.55K
Employees
103
Market Cap
51.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 4.69M | 335.00K | 7.69% |
| Jun 30, 2024 | 4.36M | 176.00K | 4.21% |
| Jun 30, 2023 | 4.18M | 1.87M | 80.80% |
| Jun 30, 2022 | 2.31M | 8.00K | 0.35% |
| Jun 30, 2021 | 2.31M | 524.08K | 29.43% |
| Jun 30, 2020 | 1.78M | -282.12K | -13.67% |
| Jun 30, 2019 | 2.06M | 314.13K | 17.96% |
| Jun 30, 2018 | 1.75M | 205.23K | 13.29% |
| Jun 30, 2017 | 1.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 2.06B |
| Terveystalo Oyj | 1.21B |
| Pihlajalinna Oyj | 571.73M |
| Revenio Group Oyj | 111.05M |
| Optomed Oyj | 16.43M |
| Biohit Oyj | 15.73M |
| Nexstim | 12.41M |
| Modulight Oyj | 10.43M |
Nightingale Health Oyj News
- 5 months ago - Nightingale Health Oyj Earnings Call Transcript: H1 2026 - Transcripts
- 5 months ago - Nightingale Health Oyj Quarterly report: H1 2026 - Filings
- 5 months ago - Nightingale Health Oyj Slides: H1 2026 - Filings
- 11 months ago - Nightingale Health Oyj Earnings Call Transcript: H2 2025 - Transcripts
- 11 months ago - Nightingale Health Oyj Annual report: H2 2025 - Filings
- 11 months ago - Nightingale Health Oyj Quarterly report: H2 2025 - Filings
- 11 months ago - Nightingale Health Oyj Slides: H2 2025 - Filings